Trifecta Clarifies No Relationship With Eli Lilly or LillyDirect Platform

Trifecta Med Spa, Trifecta Health, and Edward Fruitman, M.D. have issued a formal correction regarding recent online statements about their business relationships. The organization clarified that it does not maintain any contractual relationship, partnership, agreement, affiliation, or cooperation arrangement with Eli Lilly, LillyDirect®, or any Eli Lilly subsidiary. This correction addresses circulating information that suggested otherwise.

The clarification extends to product preferences and endorsements as well. Trifecta confirmed it does not endorse, promote, or show preference for any Eli Lilly products, including Zepbound®, within its medical or weight-loss services. This statement reinforces the organization's commitment to maintaining clinical independence from pharmaceutical manufacturers in its treatment recommendations and service delivery.

Regarding pharmacy relationships, Trifecta stated it will continue cooperating with any licensed pharmacy or pharmacy service provider that can offer optimal quality of care, value, and pricing for patients. The organization specifically noted it has not entered—nor does it plan to enter—into any exclusive pharmacy arrangement, product preference policy, or partnership with Eli Lilly or LillyDirect®. This approach allows Trifecta to maintain flexibility in selecting pharmacy partners based solely on patient benefit criteria.

Trifecta Health and Trifecta Med Spa emphasized their ongoing commitment to providing evidence-based, patient-centered weight-loss and wellness services free from manufacturer or pharmacy influence. This commitment to unbiased care represents a significant aspect of their clinical philosophy and practice standards. The organization maintains its focus on delivering treatments and recommendations based solely on medical evidence and individual patient needs rather than external commercial relationships.

For additional information about their services and approach, Trifecta directs interested parties to visit https://trifectamedspanyc.com/weight-management-program. This clarification matters significantly in the healthcare industry where transparency about manufacturer relationships helps maintain patient trust and ensures clinical decisions remain focused on patient welfare rather than commercial considerations. The statement provides important context for patients evaluating weight management options and reinforces the importance of independent clinical judgment in medical weight loss programs.